Acneiform Rash: Common Side Effect in Patients on EGFR-Targeting Therapies

A common side effect of therapies targeting the epidermal growth factor receptor (EGFR) is an acneiform rash. This rash is a frequent occurrence in patients undergoing these treatments. EGFR-targeting therapies are designed to interfere with the function of the EGFR protein. As a result, a notable number of patients experience an acneiform rash as an adverse reaction. The rash’s prevalence highlights its significance as a consideration in EGFR-targeted treatment regimens.

Newsflash | Powered by GeneOnline AI
Date: April 28, 2025

Related posts:

Study Reveals Cognitive Decline Linked to Low-Normal Vitamin B12 Levels Roger Perlmutter’s New Biotech Startup Secures $350 Million in Funding Breakthrough in Cancer Vaccine Development Enhances Effectiveness and Reach Anne Wojcicki’s Bold Move to Reclaim 23andMe Sparks Debate in Biotech Industry

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後